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SUPPLEMENTAL METHODS 
2.1 Animals and diet 
Experiments were performed using 15 New Zealand White rabbits (10-11 weeks old, 
2.33±0.12 Kg at the beginning of the study). Animal handling protocols conformed to United 
States National Institutes of Health Guidelines for the Care and Use of Laboratory Animals 
(National Institutes of Health publication nº 85-23, revised 1996) and the European 
(D2003/65/CE and R2007/526/CE) Guidelines for the Care of Animals Used in Experimental 
and other Research Purposes, and were approved by the University Committee on Use and 
Care of Animals (UCUCA) of the University of Michigan, Ann Arbor. 
The animals were housed under controlled conditions of temperature (20±1.5oC) and 
humidity (50±5%), with a 12-h light cycle, and fed standard rabbit chow (Laboratory rabbit diet 
Purina 5326, LabDiet, MO, US). After a period of 2 weeks of acclimation the rabbits were 
randomly assigned to the control group (C; n=7), which was fed with the normal chow, or to the 
experimental group (HFD; n=8), which was fed with a high fat diet. The high-fat group was fed 
ad libitum with a high fat diet, which consisted of the standard rabbit chow with an additional 
15% fat (10% corn oil and 5% lard, Research Diets Inc., NJ, US), as described previously [1]. 
Both groups were kept on their respective diets for 18 weeks.  
Supplemental table 1 shows the composition and calories provided by the control chow and 
the high-fat chow. The standard rabbit chow used was Laboratory Rabbit Diet High Fiber #5326 
(LabDiet, St. Louis, MO, US) with the following ingredients: alfalfa meal, ground soybean hulls, 
wheat middlings, cane molasses, ground yellow corn, soybean meal, salt, calcium carbonate, 
dicalcium phosphate, animal fat preserved with BHA, vitamin A acetate, cyanocobalamin, 
choline chloride, calcium pantothenate, folic acid, nicotin acid, pyridoxine hydrochloride, DL-
methionine, dl-alpha tocopheryl acetate, cholecalciferol, cobalt carbonate, riboflavin, copper 
sulfate, ferrous carbonate, magnesium oxide, manganous oxide, calcium iodate, zinc sulfate, 
zinc oxide and sodium selenite. Regarding the chemical composition, the control rabbit chow 
composition was: 14.5% protein, 2.2% fat, 21.1% fiber, 43.3% nitrogen-free extract and 18.9% 
other components. This represents a 23.1 % of calories provided by proteins, 7.9 % by fat and 
69.1 % by carbohydrates. 
 
2.2. Experimental protocol 
After the two weeks of acclimation, and before starting the diet, rabbits were placed in a 
rabbit restrainer and were anesthetized with intramuscular injection of Ketamine (KetaVed, 25 
mg/kg) and Xylazine (Anased, 10 mg/kg). Once the rabbits were sedated, and after waiting at 
least, a minimum of 10 minutes after the injection, blood glucose, electrocardiography and 
echocardiography studies were performed. The weight of the animals was monitored weekly. 
After 18 weeks, and 2-3 days before euthanizing the animals, the same procedure was followed 
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and the blood glucose, electrocardiography and echocardiography measurements were 
performed, in addition to an intravenous glucose tolerance test and morphological 
measurements. When euthanasia was performed, and prior to the electrophysiological 
experiment in isolated rabbit heart, blood samples were collected. 
 
2.3. Morphological measurements 
 
Body measurements were taken by means of measuring tapes and a weighing scale before 
performing the glucose tolerance test. Body weight, body length, body mass index (BMI), 
abdominal circumference and abdominal circumference/body length ratio were determined. 
 
2.4. Intravenous glucose tolerance test 
 
For the evaluation of glucose metabolism, intravenous glucose tolerance test (IVGTT) was 
performed as previously described [2]. Rabbits were fasted overnight and the experiment 
started between 8 and 9 a.m. After anesthesia, a bolus of glucose (600 mg/kg) was 
administered i.v. through the marginal ear vein and blood samples were taken before and at 
different time points (10, 20, 30, 60, 90, 120 and 240 minutes) after injection. Blood glucose was 
measured with a glucose meter (Precission Xtra, Abbot Diabetes Care, CA, US). The area 
under the curve (AUC) was calculated by multiplying the cumulative mean height of glucose 
(mg/dL) by the time (hours) [3]. 
 
2.5. Echocardiographic study 
 
Transthoracic echocardiography was performed as in earlier studies [4] before and 18 
weeks after starting the high fat diet, using Vevo 2100 ultrasound system (Visualsonics, ON) 
with a MS200 9–18 MHz Cardiovascular MicroScan transducer up to 30 micron resolution and 
frame rates in 2D up to 740 frames/second (for a 4x4 mm field of view). Doppler, m-mode, 
tissue doppler and 2D protocols were used. The main parameters of analysis included ejection 
fraction, cardiac output, fractional shortening, left atrium (LA), left ventricle posterior wall 
(LVPW), interventricular septum (IVS) and left ventricle (LV), diameter, volume, mass and 
thickness. The parameters analyzed in each of the protocols are detailed in Supplemental table 
2. Analyses were performed by an experienced echocardiographer (Kimber Converso-Baran) 
blinded to the study. 
 
2.6. Electrocardiographic study 
 
ECG recordings (of 500 s duration) were made by means of two standard bipolar leads 
connected to a P511 amplifier (Grass Technologies, RI, US) with a sampling rate of 1 kHz. The 
experiments were performed between 9 and 10 a.m., after anesthesia. P-P and R-R intervals, 
P-wave duration and dispersion, QRS duration, P-R interval and QT interval were analyzed with 
Clampfit ver. 10.2.0.12 (Molecular Devices, CA, US) and the mean of 25 consecutive beats was 
used in each animal for quantification. Corrected QT interval (QTc) was calculated according to 
the formula:  QTc = QT-0.175(RR-300) [5]. QTc dispersion was assessed as the difference 
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between the maximum and minimum QTc interval. Similarly, P wave dispersion was computed 
as the difference between the maximum and minimum P-wave duration. 
Additionally, we quantified short-term heart rate variability (HRV) in 500 s recordings. Time-
domain, geometrical and nonlinear standard HRV parameters were quantified using Kubios 
HRV software [6] (Supplemental table 3). 
 
2.7. Electrophysiological study  
 
Optical mapping was performed as described in previous studies [7,8,9]. Briefly, following 
sedation, rabbits were treated with heparin and anesthetized with sodium pentobarbital (50-100 
mg/kg, administered intravenously via ear marginal vein). Upon reaching surgical-level 
anesthesia, hearts were quickly removed and immersed in cold (4°C) cardioplegic solution for 
further preparation. The aorta was cannulated and connected to a Langendorff system to 
perfuse the heart with warmed, oxygenated Tyrode’s solution (pH 7.4) containing (in mM) 130 
NaCl, 5.4 KCl, 1.8 CaCl2, 0.6 MgCl2, 1.4 NaH2PO4, 25 NaHCO3, and 10 glucose. Oxygenation 
was carried out with a mixture of 95% O2 and 5% CO2. The heart was immersed in the same 
Tyrode’s solution, in a custom-made plastic chamber, and the temperature of both the perfusate 
leaving the cannula and that in the superfusion chamber was maintained at 35.5±1.5ºC. The 
perfusion pressure was maintained between 60-70 mm Hg, by means of controlling the flow of 
the perfusate, at ~30-40 ml/min. Blebbistatin (5-10µM, Sigma) was added to the perfusate to 
uncouple electrical impulses from contraction, thus minimizing motion artifact. Blebbistatin has 
been shown to have minimal effect on rabbit ventricular electrophysiology [10]. A 1-2 ml bolus of 
the voltage-sensitive dye Di-4-ANEPPS (10 μM, Sigma) was added to the perfusion line. Green 
light from a 532nm, 1 Watt laser was directed at the anterior surface of the heart and emitted 
light passed through a 650±50nm filter before being captured by a high-resolution 80x80 pixel 
Little Joe CCD camera, at 1kHz sampling frequency. The typical duration of a recorded optical 
movie was 5 seconds.  
Stimulation was performed by means of a silver wire bipolar electrode (0.5 mm 
interelectrode distance, 0.25 mm electrode diameter) positioned on the right ventricle 
epicardium near the outflow tract. Electrical stimuli with an intensity 2 times the diastolic 
threshold were delivered by an A310 Accupulser stimulator (World Precision Instruments, FL, 
US) connected to a stimulus isolation unit (A385, World Precision Instruments, FL, US). Volume 
conducted ECGs (pseudo lead 1) were acquired at 1 KHz using a P511 AC amplifier (Grass 
Technologies, RI, USA). The hearts were paced at 4, 4.4, 5, 5.7, 6.6, 8 and 10 Hz (250, 225, 
200, 175, 150, 125, and 100ms cycle length, respectively) under different extracellular 
potassium concentrations, in normo- and hyperkalemia (4, and 12mM [K+]o respectively), and 
during perfusion with the beta adrenergic agonist isoproterenol (100 nM). Measurements of 
conduction velocity (CV) of the impulse propagation in the heart show a classic biphasic 
response, when the extracellular K+ levels are gradually increased; i.e. if extracellular K+ is 
increased from 4 to 6-8 mM, the CV actually increases, and then slows down as further 
increases in K+ follow, i.e. > 10 mM (see the classic experiments by Kagiyama et al. [17] in this 
regard; and also simulations that were able to reproduce this phenomenon [18]. Thus the choice 
of high K+ (12 mM) was dictated by the attempt to avoid the biphasic phase where CV 
increases, instead of slowing down. Ventricular fibrillation (VF) was triggered by pacing at 
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increasing frequencies. Optical action potential duration (APD) at 80% of repolarization 
(APD80), conduction velocity (CV), dominant frequency (DF), regularity index (RI) and 
singularity points density (SPD) measurements were made. Analytical tools developed by 
members of our laboratory (Dr. Sergey Mironov: SCROLL) were used to calculate these 
parameters, as in previous studies [11,12]. 
 
2.8. Parameters in plasma 
 
Postheparin plasma was collected from rabbits at week 18, 10 minutes after a bolus 
injection of heparin at a dose of 30 U/Kg body weight. Triglycerides (TG), total cholesterol (TC) 
and high-density-lipoprotein (HDL) cholesterol were determined by standard enzymatic 
procedures using reagent kits (Num. 3034658, 3313018 and 3034569, Roche Diagnostics, IN, 
US). 
 
2.9. Statistical analysis 
 
Values are reported as mean ± standard deviation (SD) unless stated otherwise. A repeated 
measures analysis of variance model with Bonferroni test for multiple comparisons and unpaired 
t-test were used when appropriate (SPSS, version 17.0 for Windows). Differences were 
considered significant at a two-tailed alpha level of p<0.05. 
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Supplemental Table 1. Composition and calories provided by the standard and high-fat chows. 
 
  Control High-fat 
kcal Component g Kcal g Kcal 
2.03 
LabDiet Laboratory Rabbit Diet High 
Fiber  #5326 
1000 2030 849.7 1724.9 
9 Corn Oil 0 0 100 900 
9 Lard 0 0 50 450 
 Red dye 0 0 0.3 0 
 TOTAL 1000 2030 1000 3075 
 Kcal/g 2.03 3.07 
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Supplemental Table 2. Description of the echocardiographic measurements. 
 
PARAMETER DESCRIPTION 
Hemodynamics 
Stroke volume LV stroke volume, Endocardial vol; d – Endocardial vol; s 
Cardiac output Cardiac output of the LV; endocardial SV * HR 
Systolic function 
LV ejection fraction 100 * ((LV Vol;d – LV Vol;s) / LV Vol;d) 
LV volume diastole ((7.0 / (2.4 + LVID;d)) * LVID;d3 
LV volume systole Left ventricular internal diameter (systole) 
LV fractional shortening 100 * ((LVID;d – LVID;s) / LVID;d) 
LV int. diameter diastole Left ventricular internal diameter (diastole) 
LV int. diameter systole ((7.0 / (2.4 + LVID;s)) * LVID;s3 
Diastolic function 
Mitral valve E vel. Mitral valve E velocity 
Mitral valve A vel. Mitral valve A velocity 
E’ septal annulus vel. Velocity at E’ septal annulus 
Mitral valve E/A Mitral valve E to A ratio 
Mitral valve E/E’septal anulus Ratio of MV E velocity to E’ velocity at septal annulus 
Isovolumic relax. time Isovolumic relaxation time 
Isovolumic cont. time Isovolumic contraction time 
Morphological parameters 
IVS diastole Inter ventricular septum thickness (diastole) 
IVS systole Inter ventricular septum thickness (systole) 
LV posterior wall diastole Left ventricular posterior wall thickness (diastole) 
LV posterior wall systole Left ventricular posterior wall thickness (systole) 
LV mass 1.053 * ((LVID;d + LVPW;d + IVS;d)3– LVID;d3) 
LA size Left Atrium in end systole from parasternal long axis view 
LA volume The volume of the LA at end systole (maximum size) 
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Supplemental Table 3. Description of the short-term HRV measurements. 
 
PARAMETER DESCRIPTION 
Time domain analysis (statistical measurements) 
RR (ms) Mean of the selected R-R interval series 
SDRR (ms) Standard deviation of the R-R interval series 
RMSSD (ms) 
The root mean square of differences of successive R-R 
intervals 
pNN50 (%) 
The percentage value of consecutive R-R intervals that 
differ more than 50 ms 
Time domain analysis (geometrical measurements) 
HRVI (a.u.) 
HRV triangular index, the integral of the sample density 
distribution of R-R intervals divided by the maximum of the 
density distribution 
TIRR (ms) 
Triangular interpolation of the R-R interval histogram. 
Baseline width of the minimum square difference triangular 
interpolation of the maximum of the sample density 
distribution of R-R intervals 
Nonlinear measures (Poincaré plot) 
SD1 (ms) The standard deviation of Poincaré plot perpendicular to the 
line of identity. It represents the instantaneous beat-to-beat 
variability 
SD2 (ms) The standard deviation of Poincaré plot along the line of 
identity. It represents the continuous long-term beat-to-beat 
variability 
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SUPPLEMENTAL RESULTS 
 
 
Supplemental Figure 1. Volume-conducted ECG parameters in optical mapping 
experiments. R-R interval (a), Coefficient of variation of R-R interval (b), P-R interval (c), 
corrected QT interval (d), QT interval dispersion (e) and QRS duration (f) in control (n=5-7) and 
HFD (n=5-8) groups. Error bars display the SEM. *p<0.05 vs control. Tyr = during Tyrode 
perfusion; Hi K+ = during high potassium (12 mM) perfusion; Iso = during isoproterenol (100 
nM) perfusion. 
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Supplemental Figure 2. Optical mapping data analysis and interpretation. Panel a shows 
an image of the isolated heart preparation (anterior view). The field of view of the camera is 
depicted by the red dashed line, and included the epicardial surface or the right (RV) and left 
ventricle (LV). Spatiotemporal filtering was applied to the movies using space filtering with 5x5 
pixel kernel size, and a 11-frame temporal filter [12,13]. Spatial filtering was done with conical 
filters, and the temporal filtering was also carried out as weighted averages over the eleven 
frames with maximal weight on the central frame [12,13]. Subsequently, background 
fluorescence was subtracted. Activation maps are shown in panel b. Activation times (deﬁned 
as the time at which each signal reached 50% of its upstroke amplitude, a value reached via 
interpolation from the recorded value above, and the value below the 50% amplitude) were 
determined for each pixel. Activation maps were constructed from activation times. Panel b 
shows typical activation maps during normal Tyrode perfusion and hyperkalemia, where we can 
observe the expected reduction in conduction velocity (isocrones = 5 ms). Typical action 
potential duration maps at 80% of repolarization (APD80) are shown in panel c. In panel d we 
superimposed examples of optical action potentials from single pixel recordings in the areas 
marked with an asterisk in panel c, in control (blue) and hyperkalemia (red), showing the 
expected reduction in APD during hyperkalemia. 
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Supplemental Figure 3. Dominant frequency (DF) analysis of the isoproterenol-induced 
ventricular fibrillation (VF). For the time series of each pixel, the power spectrum density was 
estimated and the frequency with the maximum power was assigned to be the DF. For each 
episode, we obtained a global DF and pixel-by-pixel DFs. The latter was presented as a map 
that gave the spatial distribution of DFs in the field of view at each time point of the arrhythmic 
episode (b). The estimation of the power spectrum was obtained by the method of Welch [14]. 
Briefly, the time series was subdivided into two partially overlapping segments. The power 
spectrum of each segment (2.13 sec long) was obtained via fast Fourier transformation and 
then averaged and normalized to the total power. The outcome of this procedure was the 
removal of the inconsistent variability, enhanced weight of the peaks, and a frequency resolution 
of 0.47 Hz. Thereafter, the 6 DF maps of each movie in an experiment were superimposed to 
construct an averaged color-coded DF map for that experiment (a). Panel c displays the 
epicardial optical signal of the pixel highlighted in panel b at 240 s after VF initiation. 
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Supplemental Figure 4. Analysis of the spectral characteristics of the arrhythmia: 
regularity index and phase maps. For each signal, regularity index (RI) was defined as the 
ratio of the power at the DF to total power [11]. The power at the DF was calculated by summing 
the power values at the highest peak and its adjacent values (fixed band of ~0.75 Hz), and the 
total power was calculated as the sum over the range of 1 to 30 Hz. Average maps of RI were 
constructed like the DF maps at each time point of the arrhythmic episode (b). Then, the 6 RI 
maps of each movie in an experiment were superimposed to construct an averaged color-coded 
DF map for that experiment (a). Phase movies were generated by applying the Hilbert transform 
to the fluorescent signals [15]. Singularity points (SPs) were defined as points where all phases 
converged [16], and were identified automatically in all VF movies. Average phase maps were 
constructed like the DF and RI maps at each time point of the arrhythmic episode (d), and 6 
phase maps of each movie in an experiment were superimposed to construct an averaged 
color-coded SPs density map for that experiment (c). 
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